112 related articles for article (PubMed ID: 37595337)
1. Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older.
Tuesley KM; Spilsbury K; Webb PM; Protani MM; Dixon-Suen S; Pearson SA; Donovan P; Coory MD; Steer CB; Stewart LM; Pandeya N; Jordan SJ
Cancer Epidemiol; 2023 Oct; 86():102444. PubMed ID: 37595337
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive Use and the Risk of Cataract in Patients with Hypertension: A Nationwide Case-control Study.
Yang HL; Byun SJ; Park S; Lee SH; Park SJ; Jung SY
Ophthalmic Epidemiol; 2023 Oct; 30(5):499-508. PubMed ID: 36369827
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive medication use and ovarian cancer survival.
Huang T; Townsend MK; Dood RL; Sood AK; Tworoger SS
Gynecol Oncol; 2021 Nov; 163(2):342-347. PubMed ID: 34556331
[TBL] [Abstract][Full Text] [Related]
4. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
[TBL] [Abstract][Full Text] [Related]
5. Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients.
Cho MA; Jeong SY; Sohn I; Kim MS; Kang JH; Paik ES; Lee YY; Choi CH
Cancer Res Treat; 2020 Apr; 52(2):645-654. PubMed ID: 32019281
[TBL] [Abstract][Full Text] [Related]
6. Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.
Tuesley KM; Webb PM; Protani MM; Spilsbury K; Pearson SA; Coory MD; Donovan P; Steer C; Stewart LM; Pandeya N; Jordan SJ
J Natl Cancer Inst; 2022 Jun; 114(6):878-884. PubMed ID: 35262727
[TBL] [Abstract][Full Text] [Related]
7. Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.
Modugno F; Fu Z; Jordan SJ; Group A; Chang-Claude J; Fortner RT; Goodman MT; Moysich KB; Schildkraut JM; Berchuck A; Bandera EV; Qin B; Sutphen R; McLaughlin JR; Menon U; Ramus SJ; Gayther SA; Gentry-Maharaj A; Karpinskyj C; Pearce CL; Wu AH; Risch HA; Webb PM
Eur J Epidemiol; 2020 Nov; 35(11):1025-1042. PubMed ID: 32959149
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
9. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.
Chen L; Malone KE; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1423-6. PubMed ID: 26084603
[TBL] [Abstract][Full Text] [Related]
10. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies.
Wiens M; Etminan M; Gill SS; Takkouche B
J Intern Med; 2006 Oct; 260(4):350-62. PubMed ID: 16961672
[TBL] [Abstract][Full Text] [Related]
11. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
12. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
13. Use of antihypertensive drugs and risk of skin cancer.
Schmidt SA; Schmidt M; Mehnert F; Lemeshow S; Sørensen HT
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1545-54. PubMed ID: 25640031
[TBL] [Abstract][Full Text] [Related]
14. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive medication use and risk of renal cell carcinoma.
Colt JS; Hofmann JN; Schwartz K; Chow WH; Graubard BI; Davis F; Ruterbusch J; Berndt S; Purdue MP
Cancer Causes Control; 2017 Apr; 28(4):289-297. PubMed ID: 28224412
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of angiotensin receptor blockers and the risk of cancer.
Azoulay L; Assimes TL; Yin H; Bartels DB; Schiffrin EL; Suissa S
PLoS One; 2012; 7(12):e50893. PubMed ID: 23251399
[TBL] [Abstract][Full Text] [Related]
18. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.
Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW
CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: impact of drug class on adherence to antihypertensives.
Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
[TBL] [Abstract][Full Text] [Related]
20. New-onset diabetes and antihypertensive treatment.
Grimm C; Köberlein J; Wiosna W; Kresimon J; Kiencke P; Rychlik R
GMS Health Technol Assess; 2010 Mar; 6():Doc03. PubMed ID: 21289876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]